|Advocacy Action News & Needs|
Get the latest news each weekday on the MPhA Twitter feed! Follow us at @MinnPharmAssoc
March 24, 2017
Your Action Needed Today to Include Changes in Medicaid Reimbursement in the State Budget!
It is critical that members contact the Chairman and staff of the House Health and Human Services Finance Committee TODAY to urge support for including HF 1819 (Pharmacy Reimbursement Modernization) in the House HHS Policy Omnibus bill currently being drafted. These changes were mandated in the CMS Outpatient Covered Drug rule, passed several years ago, and provide much needed relief for pharmacies from Minnesota's chronically low Medicaid reimbursement. Without your urgent help, Minnesota will not be on track to comply with the CMS Covered Outpatient Drugs Rule as required by April 1.
You don't need to be an expert on the bill or go into a lengthy explanation. Just call or email one or more of the three people below, tell them who you are, and tell them something to the effect that you urge them to include HF 1819, Pharmacy Reimbursement Modernization, in the HHS (Health & Human Services) Omnibus bill that is currently being drafted, and then thank them. That's it!
Please share this alert with your pharmacy team and ask they that they call and send an email TODAY!
House Health and Human Services Finance Chairman Matt Dean, email@example.com
March 17, 2017
MPhA Legislative Action Alert Succeeds!
On March 6, MPhA asked our members to contact Minnesota Representative Joe Schomacker to request a hearing on House File 1819. You called and emailed — and your voices were heard! The bill was heard in his committee and passed on to the finance committee, where it was heard and rolled over for inclusion in the overall (omnibus) HHS finance bill. We are relatively confident of a hearing in the Senate.
March 3, 2017
Prescription Drug Price Transparency Act Introduced
Reps. Doug Collins (R-Ga.) and Dave Loebsack (D-Iowa) have introduced H.R. 1316, the Prescription Drug Price Transparency Act. The bill’s other original sponsors are Reps. Brian Babin (R-Texas), Rod Blum (R-Iowa), Buddy Carter (R-Ga.), John Duncan, Jr. (R-Tenn.), Cathy McMorris Rodgers (R-Wash.), and John Sarbanes (D-Md.). The bill would:
The National Community Pharmacists Association has announced strong support for the bill.
February 24, 2017
Pharmacy Advocacy at Work at the Minnesota Legislature
SF 1049 was introduced in the Minnesota Senate on Feb. 16. This is the companion to HF 1140, and would grant pharmacists the authority to prescribe self-administered hormonal contraceptives, nicotine replacement products, opiate antagonists, and travel medications. Our authors in the Senate are Tony Lourey of Duluth, Julie Rosen of Vernon Center, John Hoffman of Champlin and Jim Abeler of Anoka. The bill has been referred to the Health and Human Services Finance and Policy Committee; three of the authors serve on this committee.
February 17, 2017
Pharmacy Advocacy at Work at the Minnesota Legislature
Thanks to everyone who attended this week’s Minnesota Pharmacy Legislative Day on Feb. 15! We nearly set a new record for attendance. Participants met with many key legislators to explain the need for HF 1140.
The week of Feb. 6 was spent finalizing the Pharmacy Advocacy Task Force (PATF) legislative language with Rep. Roz Peterson's office and the House Research and Revisor's staff. The "jacket" with the PATF legislative language/bill was walked around for signature with help from MPhA members and others.
Buck Humphrey and volunteers met with legislators to secure their sponsorship of our legislation and to further educate additional legislators about what we are seeking and what our legislation is trying to accomplish. On Feb. 10, Humphrey dropped our legislation, chief-authored by Rep. Roz Peterson, in the Hopper for introduction in General Orders on Feb. 13. Additional sponsors in the House include Rep. Dave Baker (R-Willmar), Rep. Tony Albright (R-Prior Lake), Rep. Rod Hamilton (R-Mountain Lake), Rep. Erin Murphy (D-St. Paul), Rep. Jennifer Schultz (D-Duluth), and Rep. Mary Franson (R-Alexandria). Senators Tony Lourey (D-Duluth), Julie Rosen (R-Vernon Center), Jim Abeler (R-Anoka) and (I can’t remember the name of the fourth senator) have agreed to serve as authors for our legislation in the Senate. If work goes as planned, our companion legislation will be introduced in the Senate by Feb. 20 or sooner.
A meeting with Minnesota Medical Association (MMA) lobbyists Dave Renner and Eric Dick went as anticipated, with the lobbyists saying they would most likely not be able to support legislation that calls specifically for pharmacist prescribing authority through a Board of Pharmacy (BOP) statewide protocol. They indicated they could potentially support a statewide protocol administered through the Department of Health for each medication category (this would include the Department's Chief Medical Officer — a doctor — signing off on the protocol). We will continue to seek common ground with MMA if possible. The MMA meeting also included discussion of a few recently introduced bills both groups could support. PATF members also had a conference call with a member of the Minnesota section of the American Congress of Obstetricians and Gynecologists (MN-ACOG); we will continue to work with MN-ACOG as members have indicated a willingness to help.
During the week of Feb. 13, PATF representatives also planned to meet with the Minnesota Nurses Association, Minnesota Nurse Practitioners and Minnesota Clear Way to brief them on the PATF bill and ask for support. In addition, PATF will continue to work with Cody Wiberg and the Minnesota BOP to further our legislative agenda.
February 10, 2017
Pharmacy Dispensing Fee Reimbursement
From the Minnesota Retailers Association: The CMS outpatient drug rule pharmacy reimbursement language and proposal for compliance with federal law was not included in Gov. Dayton's budget proposal.
The Minnesota Retailers Association (MnRA) is working with Administration officials and other stakeholders proactively on next steps to ensure this important measure is included is budgetary discussions this session. MPhA is also monitoring this issue.
As a reminder, to comply with the final pharmacy reimbursement ruling from Center for Medicare and Medicaid Services (CMS), last year the Minnesota Department of Human Services (DHS) outlined the following methodology:
Pharmacy Reimbursement - RETAIL AND LTC
Pharmacy Reimbursement OTC Drugs
Annual Financial Impact by (Pharmacy Type)
Annual Financial Impact by (Prescription Type)
TOTAL FISCAL NOTE STATE IMPACT AT LEGISLATURE
Uniform State Labor Standards Passes House Committee
From the Minnesota Retailers Association: After four hours of testimony, HF 600 (the Uniform State Labor Standards Act) passed out of the House Jobs Committee and was sent to its next committee stop. Several retailers, MnRA and others provided testimony surrounding the difficulties created by a patchwork of local labor regulations. MnRA Board Members Steve Rush, Holiday Companies, and Dave Reuter, Thrifty White Pharmacy, provided House Committee members context surrounding the importance of a statewide approach to labor law uniformity.
MnRA Government Relations Director and Legal Counsel Brian Carr told Committee members during his testimony, "Retailers will be greatly impacted by the new significant increase in their administrative duty to comply with an additional third layer of local labor laws, in addition to already complying with state and federal law." HF 600 would preempt local municipalities from establishing independent policies on wage, leave, and scheduling by solidifying the State has the sole authority to act in these areas. See MnRA's press statement thanking legislators in both parties for beginning the conversation on labor law uniformity.
February 3, 2017
CMS Posts Medicare Part D/DIR Fact Sheet
The Centers for Medicare and Medicaid Services (CMS) has posted a fact sheet about Medicare Part D – Direct and Indirect Remuneration (DIR). The fact sheet provides information about trends in DIR, including charts and links to additional information. In recent years, CMS has observed a notable growth in DIR fees collected and reported by Part D sponsors.
Pharmacy Advocacy Task Force Report
The 2017 session of the Minnesota Legislature is off to a fast start. The House, Senate and Governor agreed on an emergency health care premium relief package, Health & Human Services (HHS) reform proposals are being introduced on a daily basis and all four HHS legislative committees are holding hearings. The Governor released his budget proposal last week, and the Republicans are responding with their own budget numbers and through the budget process hearings, which are set by the Chairs.
Representing the Pharmacy Advocacy Task Force (PATF), Buck Humphrey and Todd Hill, both with Capitol Hill Strategies, along with other pharmacy ambassadors (including MPhA Past President Jeff Lindoo) have been making visits to House and Senate members plus members of the governor’s staff who will be key to introducing and passing our agenda.
PATF representatives will also meet with the OB-GYNs, medical manufacturers and other stakeholders to inform them about our agenda and ask for their support. Buck Humphrey is working with MPhA Interim Executive Director Marsha Millonig and her very capable group of UM pharmacy students to complete the National Governors Association (NGA) legislative scope of practices change tool. The pharmacy students are a great help in this effort. The House HHS policy committee held an entire hearing this past week about the use of the tool for scope of practices proposed changes.
The PATF has also been working with Minnesota Board of Pharmacy Executive Director Cody Wiberg in a technical advisory capacity to draft our legislative language. Rep. Roz Peterson's office is helping with the Revisor's office to draft the legislation. This bill language can be modified if need be throughout the legislative process. Watch for more information soon.
January 27, 2017
U.S. House Introduces Pharmacy Provider Status Bill
From information provided by the National Alliance of State Pharmacy Associations and other sources: On January 20, Representatives Brett Guthrie (R-KY), G. K. Reed (D-NC), Todd Butterfield (R-IN), and Ron Kind (D-WI), along with 104 of their colleagues have reintroduced the Pharmacy and Medically Underserved Areas Enhancement Act (H.R. 592 for the second straight Congress). Among the bipartisan co-sponsors are Representatives Tom Emmer, Erik Paulsen, Collin Peterson and Tim Walz from Minnesota.
Here are some resources to help:
Both of Minnesota’s senators have signed on as co-sponsors of the companion bill in the U.S. Senate (S. 109).
If your representative has not yet signed on, please contact him or her to ask for support on this bill. Here are some resources to help:
The Minnesota Pharmacists Association is a partner in the Patient Access to Pharmacists’ Care Coalition (PAPCC). PAPCC is a group of more then 35 national and 70 state organizations representing patients, pharmacists, pharmacies, and other interested stakeholders.
Help Keep Pro-Pharmacy Provisions of ACA
From the National Community Pharmacists Association: Urge your U.S. Senators and Representatives to support bipartisan pro-pharmacy provisions of the Affordable Care Act (ACA). Congress is moving toward repeal of the ACA, and the following measures would no longer be available unless they are included in replacement legislation:
Congress intends to move swiftly on this issue, so make your voice heard today! Visit the NCPA Legislative Action Center — you’ll be able to send messages to both Senators and your Representatives with just a few keystrokes!
January 20, 2017
CMS Releases Analysis of Part D DIR Fees
The Centers for Medicare & Medicaid Services (CMS) released an analysis related to Part D Direct and Indirect Remuneration (DIR) fees and the impact of these fees on the Part D program on January 19. Read the summary. Among the findings: CMS “has observed a growing disparity between gross Part D drug costs, calculated based on costs of drugs at the point-of-sale, and net Part D drug costs, which account for all DIR.”
January 13, 2017
Provider Status Legislation Reintroduced in U.S. Senate
From information provided by the American Pharmacists Association and the National Association of Chain Drug Stores: On Thursday, January 12, the Pharmacy and Medically Underserved Areas Enhancement Act (S. 109) was reintroduced in the U.S. Senate with the bipartisan original co-sponsorship of more than one-quarter of the body — including Minnesota Senators Amy Klobuchar and Al Franken. The companion legislation is expected to be reintroduced in the U.S. House of Representatives soon. The National Association of Chain Drug Stores (NACDS) strongly backs the legislation.
“NACDS truly appreciates the leadership of Senator Chuck Grassley (R-IA), Senator Susan Collins (R-ME), Senator Sherrod Brown (D-OH), and Senator Bob Casey (D-PA) in re-introducing the Pharmacy and Medically Underserved Areas Enhancement Act as lead sponsors,” said NACDS President and CEO Steven C. Anderson, IOM, CAE. “NACDS thanks all of the 27 Senators who have made a powerful statement about this legislation by signing on as original cosponsors and sustaining this bill’s momentum from the 114th Congress into the current 115th Congress.”
Thanks to the work of pharmacists across the nation, provider status legislation had 296 co-sponsors in the House and 51 co-sponsors in the Senate at the end of 2016. Once the bill is reintroduced in the House, the American Pharmacists Association and other pharmacy organizations will ask pharmacists and others to contact your Members of Congress to encourage them to support the legislation by becoming a co-sponsor or to thank them if they are already a co-sponsor.
Visit www.pharmacistsprovidecare.com to learn more about the profession’s provider status campaign. More information is also available through the “Provider Status” tag on NACDS.org, as well as on the website of the Patient Access to Pharmacists’ Care Coalition, a group of organizations representing patients, pharmacists, pharmacies and others. NACDS is a founding member of the Coalition and serves on its Steering Committee.8
December 16, 2016
President Signs Bill Aimed at Speeding Process for Drug, Device Approval
From American Pharmacists Association: On Dec. 13, President Obama signed a far-reaching law that will speed the process for approving drugs and medical devices and increase funding for medical research. The 21st Century Cures Act also provides funding for mental health and substance use disorder prevention and treatment. Although the bill does not specifically mention pharmacists, several provisions could have implications for our profession. Read the full article.